We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+2.93%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$768M
AUM Growth
+$22.1M
Cap. Flow
+$2.91M
Cap. Flow %
0.38%
Top 10 Hldgs %
32.63%
Holding
159
New
5
Increased
19
Reduced
83
Closed
3

Sector Composition

Rank Sector Weight
1 Healthcare 22.84%
2 Technology 22.56%
3 Industrials 18.94%
4 Utilities 17.38%
5 Communication Services 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFCR icon
151
Lifecore Biomedical
LFCR
$165M
-367,171
Closed -$3.89M
OTTR icon
152
Otter Tail
OTTR
$3.79B
-12,400
Closed -$573K

Similar funds

John G. Ullman & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, John G. Ullman & Associates held 159 positions worth $768M, up 3% from $745M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q2 2021 filing shows 5 new, 19 increased, 83 reduced and 3 closed positions. Its largest new stake was Tutor Perini Cor: 269,100 shares worth $3.73M. The largest sale was ExxonMobil, an estimated $7.84M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • John G. Ullman & Associates's largest Q2 2021 buy was Tutor Perini Cor: 269,100 shares worth $3.73M.
  • John G. Ullman & Associates added most to Verizon in Q2 2021, an estimated $10.2M increase.
  • John G. Ullman & Associates's biggest Q2 2021 reduction was ExxonMobil, cutting an estimated $7.84M.
  • John G. Ullman & Associates fully exited Lifecore Biomedical in Q2 2021, selling an estimated $3.89M.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $768M portfolio in Q2 2021.
  • John G. Ullman & Associates opened 5 new positions and closed 3 in Q2 2021.
  • John G. Ullman & Associates's portfolio value rose 3% quarter-over-quarter to $768M.

Based on John G. Ullman & Associates's 13F filing for Q2 2021, filed 23 Jul 2021.